Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTW.L Regulatory News (MTW)

  • There is currently no data for MTW

Trading Update

17 Dec 2021 07:00

RNS Number : 0157W
Mattioli Woods PLC
17 December 2021
 

 

 

17 December 2021

 

Mattioli Woods plc

 

("Mattioli Woods", "the Company" or "the Group")

 

Trading Update

 

Mattioli Woods (AIM: MTW.L), the specialist wealth and asset management business, today issues the following trading update for the six months ended 30 November 2021.

 

Net inflows into the Group's investment and asset management services and the number of new clients on-boarded in the financial year to date are ahead of the prior year, reflecting the strength of existing client referrals and new business initiatives. These initiatives are also driving an increasing pipeline of new business enquiries, with organic revenue growth in excess of 10 per cent. for the period.

 

Each of the Group's recent acquisitions are performing and integrating well. The anticipated revenue and cost synergies identified on Mattioli Woods' acquisitions of Maven Capital Partners and Ludlow Wealth Management are already starting to be realised, with both businesses trading ahead of budget for the year to date.

 

We anticipate further consolidation within the wealth management, pensions administration and financial planning sectors, with many more opportunities coming to market. The Group expects to build upon its strong track record of successful acquisitions by continuing to assess and progress bolt-on opportunities in the nearer term as well as potentially more substantial opportunities in the longer term, with all required to meet its strict investment criteria.

 

The Group's trading outlook for the current financial year remains in line with management's expectations and Mattioli Woods remains well-positioned to deliver sustainable shareholder returns.

 

A fuller trading update is expected to be released in early January 2022.

 

- Ends -

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018."

 

For further information please contact:

 

Mattioli Woods plc

Ian Mattioli MBE, Chief Executive Officer

Ravi Tara, Chief Financial Officer

Tel: +44 (0) 116 240 8700

Michael Wright, Group Managing Director

www.mattioliwoods.com

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Adam James

Tel: +44 (0) 20 7523 8000

Thomas Diehl

www.canaccordgenuity.com

Singer Capital Markets (Joint Broker)

Justin McKeegan

Tom Salvesen

Tel: +44 (0) 20 7496 3000

Alaina Wong

www.singercm.com

 

Media enquiries:

Camarco

Julia Tilley

Tel: +44 (0) 20 3757 4998

Daniel Sherwen

www.camarco.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKOBPABDKOBD
Date   Source Headline
1st Apr 202211:00 amRNSTotal Voting Rights
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:20 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSAppointment of Non-Executive Chairman
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
15th Feb 20224:40 pmRNSHolding(s) in Company
11th Feb 20225:30 pmRNSDirector/PDMR Shareholding
10th Feb 20226:25 pmRNSHolding(s) in Company
9th Feb 20225:00 pmRNSDirector/PDMR Shareholding
8th Feb 20227:00 amRNSInterim Results
1st Feb 20223:02 pmRNSTotal Voting Rights
21st Jan 20227:00 amRNSUpdate to Appointment of Non-Executive Chairman
7th Jan 20225:41 pmRNSDirector/PDMR Shareholding
7th Jan 20223:59 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSTrading Update and Notice of Interim Results
5th Jan 20228:40 amRNSTotal Voting Rights
30th Dec 20215:30 pmRNSDirector/PDMR Shareholding
30th Dec 20214:45 pmRNSAdditional Block Listing
24th Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSTrading Update
13th Dec 20213:56 pmRNSHolding(s) in Company
10th Dec 20213:42 pmRNSHolding(s) in Company
7th Dec 20215:35 pmRNSHolding(s) in Company
1st Dec 202111:00 amRNSTotal Voting Rights
18th Nov 20213:15 pmRNSHolding(s) in Company
12th Nov 20213:30 pmRNSDirector/PDMR Shareholding
1st Nov 20213:00 pmRNSTotal Voting Rights
29th Oct 20213:56 pmRNSResults of Annual General Meeting
29th Oct 20217:00 amRNSAGM Statement and resolution update
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
1st Oct 20211:18 pmRNSTotal Voting Rights
1st Oct 20217:30 amRNSAppointment of Chairman
1st Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Sep 20219:45 amRNSHolding(s) in Company
21st Sep 20217:08 amRNSFinal Results for the Year Ended 31 May 2021
3rd Sep 20217:00 amRNSUpdate on Timing of Full Year Results Announcement
1st Sep 20212:54 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSLudlow Wealth Management Acquisition Update
27th Aug 20217:00 amRNSAcquisition of Richings Financial Management Ltd
13th Aug 20212:45 pmRNSAmendment to Notice of Final Results
2nd Aug 20214:00 pmRNSTotal Voting Rights
9th Jul 202112:30 pmRNSHolding(s) in Company
8th Jul 20215:10 pmRNSHolding(s) in Company
8th Jul 20217:01 amRNSHolding(s) in Company
8th Jul 20217:00 amRNSDirector/PDMR Shareholding
8th Jul 20217:00 amRNSHolding(s) in Company
7th Jul 20212:45 pmRNSHolding(s) in Company
7th Jul 20211:00 pmRNSHolding(s) in Company
7th Jul 20219:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.